Although 3D printing and the future are consistently mentioned together, what is already happening in the here and now is of great importance—and inspiration. We see 3D printing being used in many different types of industry, as well as factories for mass production already. Engineers are also using 3D printing to create parts for rocket engines and space robots, cars, homes, and so much more. And while researchers are working on new methods that may not come to fruition for years, what they have done so far—and what they are working toward—is already having an enormous impact in areas like medicine.
The University of Florida partners an innovative lab where researchers with backgrounds in physics, engineering, and medical research are all contributing and collaborating in a high-tech incubator known as the Advanced Regenerative Manufacturing Institute (ARMI). Their website describes the New Hampshire-based center’s purpose as the ‘manufacturing of the future of biofabrication.’
“ARMI will make practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones,” states the Institute as their mission.
PhD student Christopher O’Bryan sees their work as a major breakthrough.
“This institute is part of a larger network of institutes… whose mission is to revitalize manufacturing in the U.S. and this institute is focused on bio-manufacturing,” said Dr. Angelini.
The bath is made up of salts that function as silicone stabilizers. Silicone is also the substrate used in their lab’s 3D printer, meaning the research team is able to fabricate structures with more detailed and complex geometries. The team has already been able to create 3D printed tubes that will be useful in medical devices such as brain shunts.
“The real invention here is the material we are printing into, the micro-gel support bath,” said O’Bryan.
“We’ve actually hooked this up to pipe fittings and flown water through it that goes in the bottom and comes out the top,” O’Bryan explained.
The team realizes that in converting MRIs and CT scans to 3D digital data for 3D printing, they can create affordable patient-specific implants for repairing deformities and defects. Dr. Angelini is also experimenting with live cancer cells that can be 3D printed.
“That’s definitely one of our goals, to take cells out of a patient, expand them, print them into micro-tissues and then test the response of those micro-tissues to drugs,” he said.
Dr. Angelini sees these tissues being 3D printed and packaged for use by a variety of companies in the future, especially those involved in drug testing. And not only does that alleviate testing performed on both animals and humans, this process should allow for the creation of many new jobs in the industry—all dedicated to the mission of finding a cure for cancer.
Discuss in the ARMI 3D Printing Cancer Cells forum thread at 3DPB.com.[Source: Fox 13]
You May Also Like
Benny Buller on VELO3D’s SPACtacular Rise in Metal 3D Printing
2021 has already been a SPACtacular year for the 3D printing industry, with several companies already announcing mergers with special purpose acquisition companies (SPACs). This includes Markforged, Rocket Lab, and...
Materialise Has Option to Acquire 3D Printing MES Company Link3D
Belgian 3D printing service and software company Materialise (Nasdaq: MTLS) has announced that it has an option to acquire Link3D. The transaction will close later this year, but the company...
3D Printing Bureaus on the Rise: Sandvik’s BEAMIT Acquires 3T Additive Manufacturing
The BEAMIT Group has acquired polymer and metal additive manufacturing (AM) provider 3T Additive Manufacturing from the German holding group AM Global. The deal represents the first step towards BEAMIT’s...
3D Printing Webinar and Virtual Event Roundup: April 10, 2021
We’ve got another packed week of webinars and virtual events for you, starting with Hannover Messe 2021 on Monday. What else is coming up this week: ASTM CoE’s personnel certificate...
View our broad assortment of in house and third party products.